Hinova Pharmaceuticals Inc.
Clinical trials sponsored by Hinova Pharmaceuticals Inc., explained in plain language.
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowThis study tests an experimental pill called HP515 for people with non-alcoholic fatty liver disease (NAFLD). About 80 adults with at least 10% liver fat will take the drug for 12 weeks. The main goal is to see if it reduces liver fat measured by MRI, while also checking safety a…
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
New pill shows promise against Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests an experimental oral drug called HP518 in men with metastatic castration-resistant prostate cancer that has stopped responding to standard hormone therapy. The goal is to find the safest dose and see if it can shrink tumors or lower PSA levels. About 84 participa…
Phase: PHASE1, PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 05:36 UTC